Please login to the form below

Not currently logged in


This page shows the latest cardiovascular news and features for those working in and with pharma, biotech and healthcare.

Bristol Myers Squibb and GentiBio in $1.9bn deal to develop IBD therapies

Bristol Myers Squibb and GentiBio in $1.9bn deal to develop IBD therapies

Robert Plenge, BMS senior vice president and head, immunology, Cardiovascular and Fibrosis Thematic Research Center and head, translational medicine said: “We are excited to collaborate with GentiBio as we explore creating

Latest news

More from news
Approximately 49 fully matching, plus 978 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 86 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 59 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 62 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company
Onyx Health

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

Environment: where does the pharmaceutical industry stand?
The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...